Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.
Acepodia has raised $100.0M in total funding. The most recent round was Series D. The last funding was announced in June 2023.
Acepodia's investors include 8VC, DEFTA Partners, CDIB Capital, Ridgeback Capital, TopTaiwan.
Acepodia is headquartered in Alameda, United States.
Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.
Acepodia is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acepodia — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/acepodia. Accessed August 13, 2026.
VCBacked. (2023). Acepodia — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/acepodia
{{cite web |title=Acepodia — Funding & Investors |url=https://www.vcbacked.co/company/acepodia |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated